Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment
The objective of this study was to investigate the noninferiority of the TDF/FTC/EFV fixed-dose combination on alternate-days versus standard regimen in virologically suppressed patients.
Design:
A randomized-controlled open-label noninferiority trial enrolling HIV-1-infected patients treated for at least 6 months with TDF/FTC/EFV fixed-dose combination, virologically suppressed (
Source: AIDS - Category: Infectious Diseases Tags: CLINICAL SCIENCE Source Type: research
More News: Atripla | Clinical Trials | HIV AIDS | Infectious Diseases | Science | Study | Toxicology | Truvada | Viread | Virology